Objective:

To evaluate a multi-marker blood test for the accurate detection of endometriosis and its potential to identify cases missed by standard imaging.

Approach:

Key Findings:

• The blood test identified many histologically confirmed cases missed by ultrasound or MRI.
• It maintained consistent performance across different phases of the menstrual cycle.
• The assay integrates multiple biological processes reflecting the systemic nature of endometriosis.

Interpretation:

The findings suggest that a blood-based diagnostic approach could significantly reduce the time to diagnosis and reliance on invasive procedures, enabling earlier intervention for symptomatic patients.

Limitations:

• Further validation in larger and more diverse populations is necessary.

Conclusion:

The study highlights the potential of integrated biomarker panels to enhance diagnostic accuracy and improve endometriosis care.

Sources:

• Journal of Minimally Invasive Gynecology
Source

Based on findings from:

Endometriosis Blood Test: An End to Years of Agony?

The Pathologist, 2026.

https://www.thepathologist.com/issues/2026/articles/april/endometriosis-blood-test-an-end-to-years-of-agony/

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.